MBNL proteins repress ES-cell-specific alternative splicing and reprogramming
Name
Burge_MBNL proteins.pdf
Size
3.18 MB
Format
Adobe PDF
Checksum (MD5)
d1e7dbdc5e8265f0425dc0e8c829ef8d
Author(s)
Han, Hong
Irimia, Manuel
Ross, P. Joel
Sung, Hoon-Ki
Alipanahi, Babak
David, Laurent
Golipour, Azadeh
Gabut, Mathieu
Michael, Iacovos P.
Nachman, Emil N.
Date Issued
June 2013
Journal
Nature
Publisher
Nature Publishing Group
Citation
Han, Hong, Manuel Irimia, P. Joel Ross, Hoon-Ki Sung, Babak Alipanahi, Laurent David, Azadeh Golipour, et al. “MBNL Proteins Repress ES-Cell-Specific Alternative Splicing and Reprogramming.” Nature 498, no. 7453 (June 5, 2013): 241–245.
Version
Author's final manuscript
Abstract
Previous investigations of the core gene regulatory circuitry that controls the pluripotency of embryonic stem (ES) cells have largely focused on the roles of transcription, chromatin and non-coding RNA regulators. Alternative splicing represents a widely acting mode of gene regulation, yet its role in regulating ES-cell pluripotency and differentiation is poorly understood. Here we identify the muscleblind-like RNA binding proteins, MBNL1 and MBNL2, as conserved and direct negative regulators of a large program of cassette exon alternative splicing events that are differentially regulated between ES cells and other cell types. Knockdown of MBNL proteins in differentiated cells causes switching to an ES-cell-like alternative splicing pattern for approximately half of these events, whereas overexpression of MBNL proteins in ES cells promotes differentiated-cell-like alternative splicing patterns. Among the MBNL-regulated events is an ES-cell-specific alternative splicing switch in the forkhead family transcription factor FOXP1 that controls pluripotency. Consistent with a central and negative regulatory role for MBNL proteins in pluripotency, their knockdown significantly enhances the expression of key pluripotency genes and the formation of induced pluripotent stem cells during somatic cell reprogramming.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1038/nature12270
